Orchid Pharma Limited, a Tamil Nadu based pharmaceutical manufacturing company, has made qualified institutions placement of 9,902,705 equity shares aggregating to ₹400 crore.

The book running lead managers to this QIP were Edelweiss Financial Services Limited and JM Financial Limited.

Luthra and Luthra Law Offices India's Capital Markets team advised Orchid Pharma on this QIP.

The transaction team was led by Geeta Dhania (Partner), with due assistance from Tripti Pandey (Senior Associate), and Associates – Sakshi Mandal, Ridhi Jain, Shreeya Srungarapu, Vedaarth Uberoi and Abhishek Gupta.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.